AuroMedics Recalls Gabapentin Capsules Due to Foreign Tablet Presence
AuroMedics Pharma LLC is recalling specific lots of Gabapentin Capsules because a Losartan/HCTZ tablet was found in the bottles.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall is classified as FDA Class II, and the presence of a foreign medication (Losartan/HCTZ) in a different drug (Gabapentin) poses a risk of unintended medication intake, which aligns with the 'High' severity criteria for risk-of-harm products where injury has not yet been reported.
Plain-English summary
AuroMedics Pharma LLC is recalling Gabapentin Capsules, USP 100 mg, distributed by Aurobindo Pharma USA, Inc. The recall is due to the presence of foreign tablets or capsules, specifically one Losartan/HCTZ tablet found in Gabapentin 1000 count bottles.
The affected product is identified by Lot # 19819029A3 with an expiration date of 08/2021. The NDC number is 65682-198-99. The product was distributed nationwide within the United States.
Consumers should check their medication for this specific lot number and expiration date. If the product matches the description, they should stop using it and contact their healthcare provider or pharmacist for guidance on next steps.
The recalled product
- Product
- Gabapentin Capsules, USP 100 mg, Rx Only, Distributed by: Aurobindo Pharma USA, Inc. Dayton, NJ 08810, NDC 65682-198-99
- Manufacturer
- AuroMedics Pharma LLC
- Category
- Drug — Prescription Medication
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 19819029A3
- Exp. 08/2021
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · AuroMedics Pharma LLC
See all →- HighFondaparinux Sodium Injection Recalled Nationwide for Subpotent Formulation
FDA (Drugs) · 2022-11-02
- HighAcyclovir Sodium Injectable Recalled for Particulate Matter
FDA (Drugs) · 2022-10-26
- LowTranexamic Acid Injection Recalled for Metal Particulate Matter
FDA (Drugs) · 2022-10-12
- SeverePolymyxin B for Injection Recalled Due to Particulate Matter Contamination
FDA (Drugs) · 2022-02-16
- SevereAuroMedics Recalls Acetaminophen Injection Due to Discoloration and pH Failures
FDA (Drugs) · 2021-02-10
Same hazard · foreign object
See all →- SevereOutshine Strawberry Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Black Cherry Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Fruit Bars Grape Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Watermelon Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02